Showing results (411-420 of 529) with videos related to
Sort By:
Pageof 53
Journal of Inherited Metabolic Disease|January 1, 1985
Biochemical phenotyping of a single sibship with both cystinosis and Fabry diseaseW A Gahl, M Adamson, I Kaiser-Kupfer, et al.European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancerP Sagaster, J Flamm, M Flamm, et al.Oncology|January 1, 1985
Phase I study of recombinant human interferon alpha-2C in patients with chemotherapy-refractory malignanciesJ T Janssen, H Ludwig, W Scheithauer, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1987
Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disordersH Ludwig, W Linkesch, H Gisslinger, et al.Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100L F Soria, E H Ludwig, H R Clarke, et al.Journal of Cell Science|April 2, 2010
Activity of protein kinase CK2 uncouples Bid cleavage from caspase-8 activationChristian T Hellwig, Agnieszka H Ludwig-Galezowska, Caoimhin G Concannon, et al.Journal of Diabetes Research|November 30, 2019
Effects of Negative Pressure Wound Therapy on Levels of Angiopoetin-2 and Other Selected Circulating Signaling Molecules in Patients with Diabetic Foot UlcerJerzy Hohendorff, Anna Drozdz, Sebastian Borys, et al.Journal of Clinical Medicine|March 8, 2020
Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn's DiseaseKinga Kowalska-Duplaga, Przemysław Kapusta, Tomasz Gosiewski, et al.Cancer|December 1, 1995
Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapyH Ludwig, E Sundal, M Pecherstorfer, et al.The Journal of Clinical Endocrinology and Metabolism|September 1, 1996
Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone diseaseM J Seibel, H W Woitge, M Pecherstorfer, et al.Pageof 53